Nelivaptan
奈利伐坦
Report date: 2025/08/13 09:15:46
NME
Base Information
Drug NameNelivaptan
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[15]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksWikipedia